129 related articles for article (PubMed ID: 11420460)
41. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
42. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
[TBL] [Abstract][Full Text] [Related]
43. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
[TBL] [Abstract][Full Text] [Related]
44. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
45. Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder.
Jurincic-Winkler C; Metz KA; Beuth J; Sippel J; Klippel KF
Anticancer Res; 1995; 15(6B):2771-6. PubMed ID: 8669862
[TBL] [Abstract][Full Text] [Related]
46. Squamous cell carcinoma of bladder after successful intravesical therapy with Bacillus Calmette-Guérin.
Brenner DW; Yore LM; Schellhammer PF
Urology; 1989 Aug; 34(2):93-5. PubMed ID: 2763404
[TBL] [Abstract][Full Text] [Related]
47. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
48. Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials.
De Jager R; Guinan P; Lamm D; Khanna O; Brosman S; De Kernion J; Williams R; Richardson C; Muenz L; Reitsma D
Urology; 1991 Dec; 38(6):507-13. PubMed ID: 1836081
[TBL] [Abstract][Full Text] [Related]
49. [A case of micropapillary bladder carcinoma].
Matsumura E; Ashikari A; Tasaki S; Kato S; Ashimine S; Machida N; Toyama H; Oshiro Y; Saito S
Hinyokika Kiyo; 2012 Jun; 58(6):279-82. PubMed ID: 22874506
[TBL] [Abstract][Full Text] [Related]
50. Urethral involvement in female patients with bladder cancer. A study of 22 cystectomy specimens.
De Paepe ME; André R; Mahadevia P
Cancer; 1990 Mar; 65(5):1237-41. PubMed ID: 2302672
[TBL] [Abstract][Full Text] [Related]
51. Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases.
Dhouib RS; Abbes I; Mrad K; Sassi S; Leila A; Driss M; Salah R; Romdhane KB
Pathologica; 2005 Oct; 97(5):338-40. PubMed ID: 16480033
[TBL] [Abstract][Full Text] [Related]
52. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
53. Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
Nieder AM; Simon MA; Kim SS; Manoharan M; Soloway MS
Urology; 2006 Apr; 67(4):737-41. PubMed ID: 16618564
[TBL] [Abstract][Full Text] [Related]
54. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
Murase T; Ito H; Ohishi M; Takashi M
Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263
[TBL] [Abstract][Full Text] [Related]
55. [Carcinoma in situ of the bladder involving the prostate with an unusual invasive pattern following BCG therapy: a case report].
Iba A; Kohjimoto Y; Inagaki T; Suzuki A; Fujii R; Senzaki H; Uekado Y; Shinka T
Hinyokika Kiyo; 2005 Oct; 51(10):681-4. PubMed ID: 16285623
[TBL] [Abstract][Full Text] [Related]
56. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
[TBL] [Abstract][Full Text] [Related]
57. Evolution of carcinoma in situ under intravesical Romanian Bacille Calmette-Guérin therapy.
Geavlete P; Taşcă C
Rom J Morphol Embryol; 1991; 37(1-2):69-74. PubMed ID: 1801982
[TBL] [Abstract][Full Text] [Related]
58. Radical cystectomy for BCG failure: has the timing improved in recent years?
Soloway MS; Hepps D; Katkoori D; Ayyathurai R; Manoharan M
BJU Int; 2011 Jul; 108(2):182-5. PubMed ID: 21070578
[TBL] [Abstract][Full Text] [Related]
59. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
60. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]